Summarized by Masters of Longevity from Nature - Biotechnology.
Human Argonaute 2–based platform: a feature article on a new programmable human-protein RNA-targeting approach for therapeutic editing, explaining scope and potential.
Key Takeaways
- Researchers engineered human Argonaute 2 (AGO2) as a programmable RNA-targeting domain enabling precise RNA editing.
- The AGO2-based platform, called ALTER, enables C-to-U RNA base editing using only human-derived proteins, reducing immunogenicity risks compared to bacterial systems.
- ALTER demonstrated higher effectiveness than dCas13-based editors while maintaining specificity suitable for therapeutic applications.
